Cargando…
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of these drugs in COVID-19 patients will also be evaluated. TRIAL DESIGN: This is a single-centre, prospective, four-...
Autores principales: | Ghati, Nirmal, Roy, Ambuj, Bhatnagar, Sushma, Bhati, Sumit, Bhushan, Sudha, Mahendran, Manjit, Thakur, Abhishek, Tiwari, Pawan, Dwivedi, Tanima, Mani, Kalaivani, Gupta, Ritu, Mohan, Anant, Garg, Rakesh, Saxena, Anita, Guleria, Randeep, Deepti, Siddharthan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598224/ https://www.ncbi.nlm.nih.gov/pubmed/33126910 http://dx.doi.org/10.1186/s13063-020-04840-y |
Ejemplares similares
-
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)
por: Ghati, Nirmal, et al.
Publicado: (2022) -
Authors’ response
por: Gupta, Ritu, et al.
Publicado: (2021) -
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
por: Gupta, Ritu, et al.
Publicado: (2021) -
Impact of various hematological and biochemical parameters on mortality in coronavirus disease 2019 (COVID-19): A single-center study from North India
por: Ghosh, Tamoghna, et al.
Publicado: (2022) -
Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients
por: Madan, Manu, et al.
Publicado: (2021)